Lukes AS - Search Results

1

12-month outcomes of the US patient cohort in the SONATA pivotal IDE trial of transcervical ablation of uterine fibroids.

Hudgens J, Johns DA, Lukes AS, Forstein DA, Delvadia D. Hudgens J, et al. Among authors: lukes as. Int J Womens Health. 2019 Jul 5;11:387-394. doi: 10.2147/IJWH.S201912. eCollection 2019. Int J Womens Health. 2019. PMID: 31308763 Free PMC article.

2

Cost effectiveness of endometrial ablation with the NovaSure(®) system versus other global ablation modalities and hysterectomy for treatment of abnormal uterine bleeding: US commercial and Medicaid payer perspectives.

Miller JD, Lenhart GM, Bonafede MM, Basinski CM, Lukes AS, Troeger KA. Miller JD, et al. Among authors: lukes as. Int J Womens Health. 2015 Jan 6;7:59-73. doi: 10.2147/IJWH.S75030. eCollection 2015. Int J Womens Health. 2015. PMID: 25610002 Free PMC article.

3

Randomized comparative trial of cervical block protocols for pain management during hysteroscopic removal of polyps and myomas.

Lukes AS, Roy KH, Presthus JB, Diamond MP, Berman JM, Konsker KA. Lukes AS, et al. Int J Womens Health. 2015 Oct 13;7:833-9. doi: 10.2147/IJWH.S50101. eCollection 2015. Int J Womens Health. 2015. PMID: 26543383 Free PMC article.

4

Three-Year Results of the SONATA Pivotal Trial of Transcervical Fibroid Ablation for Symptomatic Uterine Myomata.

Lukes A, Green MA. Lukes A, et al. J Gynecol Surg. 2020 Oct 1;36(5):228-233. doi: 10.1089/gyn.2020.0021. Epub 2020 Oct 1. J Gynecol Surg. 2020. PMID: 33061253 Free PMC article.

5

Long-term evaluation of safety and health-related quality of life in women with heavy menstrual bleeding treated with oral tranexamic acid.

Muse K, Lukes AS, Gersten J, Waldbaum A, Mabey RG, Trott E. Muse K, et al. Among authors: lukes as. Womens Health (Lond). 2011 Nov;7(6):699-707. doi: 10.2217/whe.11.65. Epub 2011 Aug 25. Womens Health (Lond). 2011. PMID: 21867401 Free article. Clinical Trial.

6

Safety of tranexamic acid in women with heavy menstrual bleeding: an open-label extension study.

Lukes AS, Freeman EW, Van Drie D, Baker J, Adomako TL. Lukes AS, et al. Womens Health (Lond). 2011 Sep;7(5):591-8. doi: 10.2217/whe.11.55. Womens Health (Lond). 2011. PMID: 21879827 Free article. Clinical Trial.

7

Daily menstrual blood loss and quality of life in women with heavy menstrual bleeding.

Lukes AS, Baker J, Eder S, Adomako TL. Lukes AS, et al. Womens Health (Lond). 2012 Sep;8(5):503-11. doi: 10.2217/whe.12.36. Womens Health (Lond). 2012. PMID: 22934724 Free article.

8

Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study.

Archer DF, Stewart EA, Jain RI, Feldman RA, Lukes AS, North JD, Soliman AM, Gao J, Ng JW, Chwalisz K. Archer DF, et al. Among authors: lukes as. Fertil Steril. 2017 Jul;108(1):152-160.e4. doi: 10.1016/j.fertnstert.2017.05.006. Epub 2017 Jun 1. Fertil Steril. 2017. PMID: 28579415 Free article. Clinical Trial.

9

Ulipristal Acetate for Treatment of Uterine Leiomyomas: A Randomized Controlled Trial.

Liu JH, Soper D, Lukes A, Gee P, Kimble T, Kroll R, Mallick M, Chan A, Gillard P, Harrington A, Sniukiene V, Shulman LP. Liu JH, et al. Obstet Gynecol. 2018 Nov;132(5):1241-1251. doi: 10.1097/AOG.0000000000002942. Obstet Gynecol. 2018. PMID: 30303900 Clinical Trial.

10

Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials.

Stewart EA, Lukes AS, Venturella R, Li Y, Hunsche E, Wagman RB, Al-Hendy A. Stewart EA, et al. Among authors: lukes as. Am J Obstet Gynecol. 2023 Mar;228(3):320.e1-320.e11. doi: 10.1016/j.ajog.2022.11.1278. Epub 2022 Nov 9. Am J Obstet Gynecol. 2023. PMID: 36370871 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page